Logo image of RBRK

RUBRIK INC-A (RBRK) Stock Fundamental Analysis

NYSE:RBRK - New York Stock Exchange, Inc. - US7811541090 - Common Stock - Currency: USD

84.02  -2.51 (-2.9%)

Fundamental Rating

3

Taking everything into account, RBRK scores 3 out of 10 in our fundamental rating. RBRK was compared to 282 industry peers in the Software industry. RBRK has a bad profitability rating. Also its financial health evaluation is rather negative. RBRK shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year RBRK has reported negative net income.
In the past year RBRK had a positive cash flow from operations.
RBRK Yearly Net Income VS EBIT VS OCF VS FCFRBRK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 -200M -400M -600M -800M -1B

1.2 Ratios

The Return On Assets of RBRK (-35.59%) is worse than 78.01% of its industry peers.
Industry RankSector Rank
ROA -35.59%
ROE N/A
ROIC N/A
ROA(3y)-52.6%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RBRK Yearly ROA, ROE, ROICRBRK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 100 -100 200

1.3 Margins

RBRK's Gross Margin of 76.45% is fine compared to the rest of the industry. RBRK outperforms 71.28% of its industry peers.
RBRK's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for RBRK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.12%
GM growth 5YN/A
RBRK Yearly Profit, Operating, Gross MarginsRBRK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 50 -50 -100

3

2. Health

2.1 Basic Checks

RBRK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RBRK has more shares outstanding
RBRK has a better debt/assets ratio than last year.
RBRK Yearly Shares OutstandingRBRK Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 50M 100M 150M
RBRK Yearly Total Debt VS Total AssetsRBRK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 500M 1B

2.2 Solvency

An Altman-Z score of 1.82 indicates that RBRK is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.82, RBRK is in line with its industry, outperforming 45.39% of the companies in the same industry.
RBRK has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as RBRK would need 3.51 years to pay back of all of its debts.
The Debt to FCF ratio of RBRK (3.51) is better than 62.77% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.51
Altman-Z 1.82
ROIC/WACCN/A
WACC11.07%
RBRK Yearly LT Debt VS Equity VS FCFRBRK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 200M -200M -400M -600M

2.3 Liquidity

A Current Ratio of 1.16 indicates that RBRK should not have too much problems paying its short term obligations.
RBRK has a worse Current ratio (1.16) than 66.31% of its industry peers.
RBRK has a Quick Ratio of 1.16. This is a normal value and indicates that RBRK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.16, RBRK is doing worse than 65.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
RBRK Yearly Current Assets VS Current LiabilitesRBRK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.78% over the past year.
RBRK shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.89%.
The Revenue has been growing by 20.54% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)49.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.51%
Revenue 1Y (TTM)43.89%
Revenue growth 3Y20.54%
Revenue growth 5YN/A
Sales Q2Q%48.67%

3.2 Future

RBRK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.91% yearly.
RBRK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 29.11% yearly.
EPS Next Y57.71%
EPS Next 2Y33.22%
EPS Next 3Y27.91%
EPS Next 5YN/A
Revenue Next Year37.58%
Revenue Next 2Y31.04%
Revenue Next 3Y29.11%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RBRK Yearly Revenue VS EstimatesRBRK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
RBRK Yearly EPS VS EstimatesRBRK Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 -0.5 -1 -1.5 -2

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RBRK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RBRK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBRK Price Earnings VS Forward Price EarningsRBRK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of RBRK is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 176.53
EV/EBITDA N/A
RBRK Per share dataRBRK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

RBRK's earnings are expected to grow with 27.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.22%
EPS Next 3Y27.91%

0

5. Dividend

5.1 Amount

RBRK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

RUBRIK INC-A

NYSE:RBRK (7/22/2025, 2:48:58 PM)

84.02

-2.51 (-2.9%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-05 2025-06-05/amc
Earnings (Next)09-09 2025-09-09
Inst Owners67.43%
Inst Owner Change1.75%
Ins Owners1.75%
Ins Owner Change49.11%
Market Cap16.26B
Analysts82.14
Price Target113.49 (35.07%)
Short Float %9.39%
Short Ratio2.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)54.17%
Min EPS beat(2)53.87%
Max EPS beat(2)54.47%
EPS beat(4)4
Avg EPS beat(4)44.18%
Min EPS beat(4)19.95%
Max EPS beat(4)54.47%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.71%
Min Revenue beat(2)4.87%
Max Revenue beat(2)8.55%
Revenue beat(4)4
Avg Revenue beat(4)5.57%
Min Revenue beat(4)2.41%
Max Revenue beat(4)8.55%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)25.06%
PT rev (3m)37.6%
EPS NQ rev (1m)1.62%
EPS NQ rev (3m)4.96%
EPS NY rev (1m)0.14%
EPS NY rev (3m)14.99%
Revenue NQ rev (1m)0.56%
Revenue NQ rev (3m)2.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 16.63
P/FCF 176.53
P/OCF 136.31
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.94
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)0.48
FCFY0.57%
OCF(TTM)0.62
OCFY0.73%
SpS5.05
BVpS-2.88
TBVpS-3.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.59%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.45%
FCFM 9.42%
ROA(3y)-52.6%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.12%
GM growth 5YN/A
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.51
Debt/EBITDA N/A
Cap/Depr 91.33%
Cap/Sales 2.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.82
F-Score7
WACC11.07%
ROIC/WACCN/A
Cap/Depr(3y)109.27%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.51%
EPS Next Y57.71%
EPS Next 2Y33.22%
EPS Next 3Y27.91%
EPS Next 5YN/A
Revenue 1Y (TTM)43.89%
Revenue growth 3Y20.54%
Revenue growth 5YN/A
Sales Q2Q%48.67%
Revenue Next Year37.58%
Revenue Next 2Y31.04%
Revenue Next 3Y29.11%
Revenue Next 5YN/A
EBIT growth 1Y46.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.57%
EBIT Next 3Y33.38%
EBIT Next 5YN/A
FCF growth 1Y188.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1167.46%
OCF growth 3YN/A
OCF growth 5YN/A